#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Dec. 28 ' 24)

 

Antiviral Res

1. WANG B, Xia H, Peng BH, Choi EJ, et al
   Pellino-1, a therapeutic target for control of SARS-CoV-2 infection and disease severity.
   Antiviral Res. 2024;233:106059.
   PubMed         Abstract available
   
   
2. SCHRELL L, Fuchs HL, Dickmanns A, Scheibner D, et al
   Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4'-fluorouridine.
   Antiviral Res. 2024 Dec 3:106046. doi: 10.1016/j.antiviral.2024.106046.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

3. SUTER J, Devos I, Matthes KL, Staub K, et al
   The health and demographic impacts of the "Russian flu" pandemic in Switzerland in 1889/1890 and in the years thereafter.
   Epidemiol Infect. 2024;152:e174.
   PubMed         Abstract available
   
   

   
   JAMA

4. ANDERER S
   CDC Calls Attention to Underuse of Antiviral Treatment in Higher-Risk Youth With Influenza.
   JAMA. 2024 Dec 27. doi: 10.1001/jama.2024.25515.
   PubMed        
   
   

   
   PLoS Comput Biol

5. CALMON L, Colosi E, Bassignana G, Barrat A, et al
   Preserving friendships in school contacts: An algorithm to construct synthetic temporal networks for epidemic modelling.
   PLoS Comput Biol. 2024;20:e1012661.
   PubMed         Abstract available
   
   

   
   PLoS One

6. BAGALA I, Namuganga JF, Nayebare P, Cuu G, et al
   Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: A serial cross-sectional study.
   PLoS One. 2024;19:e0312554.
   PubMed         Abstract available
   
   
7. ZHANG Y, Guo X, Su Y
   Spatiotemporal dynamic and regional differences of public attention to vaccination: An empirical study in China.
   PLoS One. 2024;19:e0312488.
   PubMed         Abstract available
   
   
8. KIM S, Aum T, Lee DG
   Depression in the COVID-19 endemic era: Analysis of online self-disclosures by young South Koreans.
   PLoS One. 2024;19:e0314881.
   PubMed         Abstract available
   
   
9. OPOKU-BOATENG YN, Opoku-Asante E, Lagarde M, Nketiah-Amponsah E, et al
   Effect of Covid-19 on maternal and child health services utilization in Ghana. Evidence from the National Health Insurance Scheme (NHIS).
   PLoS One. 2024;19:e0311277.
   PubMed         Abstract available
   
   
10. TARIGAN S, Sekarmila G, Apas, Sumarningsih, et al
    Challenges and strategies in the soluble expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD fusion proteins as candidates for COVID-19 intranasal vaccines.
    PLoS One. 2024;19:e0306153.
    PubMed         Abstract available
    
    
11. VALDERRAMA-BELTRAN SL, Cuervo-Rojas J, Rondon M, Montealegre-Diaz JS, et al
    Development of a diagnostic multivariable prediction model of a positive SARS-CoV-2 RT-PCR result in healthcare workers with suspected SARS-CoV-2 infection in hospital settings.
    PLoS One. 2024;19:e0316207.
    PubMed         Abstract available
    
    
12. JIMENEZ-CAMPOS AG, Maestas LI, Velappan N, Beck B, et al
    A cell-based Papain-like Protease (PLpro) activity assay for rapid detection of active SARS-CoV-2 infections and antivirals.
    PLoS One. 2024;19:e0309305.
    PubMed         Abstract available
    
    
13. FENTA EH, Tassew B, Abera A, Wolde FB, et al
    Maintaining essential healthcare services in Addis Ababa during COVID-19: A qualitative study.
    PLoS One. 2024;19:e0308534.
    PubMed         Abstract available
    
    
14. HUI CY, Condon K, Kolekar S, Roberts N, et al
    Implementing digital respiratory technologies for people with respiratory conditions: A protocol for a scoping review.
    PLoS One. 2024;19:e0314914.
    PubMed         Abstract available
    
    
15. SCHICK RC, Bast H, Frank M, Urban T, et al
    Simulated low-dose dark-field radiography for detection of COVID-19 pneumonia.
    PLoS One. 2024;19:e0316104.
    PubMed         Abstract available
    
    
16. ROMASZKO-WOJTOWICZ A, Doboszynska A, Piechnik A, Kuziemski K, et al
    Impact of the COVID-19 pandemic on lung cancer diagnosis in northern Poland-addressing the COVID-19 debt.
    PLoS One. 2024;19:e0316261.
    PubMed         Abstract available
    
    
17. ALI MA, Shaker OG, Ezzat EM, Ali ESG, et al
    Peripheral lncRNA NEAT-1, miR374b-5p, and IL6 panel to guide in COVID-19 patients' diagnosis and prognosis.
    PLoS One. 2024;19:e0313042.
    PubMed         Abstract available
    
    
18. HADID D, Correia RH, McDonald SD, Darling EK, et al
    Assessing the impact of the COVID-19 pandemic on uptake and experiences of gestational diabetes mellitus screening in Ontario: A parallel convergent mixed-methods study.
    PLoS One. 2024;19:e0315983.
    PubMed         Abstract available
    
    

    
    Vaccine

19. WANG J, Tonnies T, Brinks R
    Seasonal influenza vaccination coverage and the social determinants of influenza vaccination among people over 50 with diabetes in Europe: Analyzing population-based SHARE data for the 2019-2020 and 2021-2022 influenza seasons.
    Vaccine. 2024;45:126646.
    PubMed         Abstract available
    
    
20. FRAIHA ALS, da Silva Santos BSA, Aguilar NR, Gallinari GC, et al
    Immunization and challenge trials in a murine model using different inactivated recombinant vaccines against H1N1 swine influenza virus circulating in Brazil.
    Vaccine. 2024;45:126638.
    PubMed         Abstract available
    
    
21. WERTHNER Q, Faehrmann L, Och K, Bragazzi NL, et al
    Client satisfaction, safety, and insights from a three-season survey on influenza vaccinations delivered at community pharmacies in Germany.
    Vaccine. 2024;45:126650.
    PubMed         Abstract available